Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Vignuzzi

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Cell Death & Disease|October 28, 2016
ZIKA virus elicits P53 activation and genotoxic stress in human neural progenitors similar to mutations involved in severe forms of genetic microcephalyVincent El Ghouzzi, Federico T Bianchi, Ivan Molineris, et al.
Nature Communications|September 22, 2021
Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potentialBjoern Meyer, Jeanne Chiaravalli, Stacy Gellenoncourt, et al.
Cell Death & Disease|November 22, 2018
Correction to: ZIKA virus elicits P53 activation and genotoxic stress in human neural progenitors similar to mutations involved in severe forms of genetic microcephalyVincent El Ghouzzi, Federico T Bianchi, Ivan Molineris, et al.
Nature Communications|May 4, 2022
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screenAlice Mac Kain, Ghizlane Maarifi, Sophie-Marie Aicher, et al.
Journal of Virology|August 19, 2016
Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA VirusesBryan C Mounce, Teresa Cesaro, Gonzalo Moratorio, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
Phospholipidosis is a shared mechanism underlying the <i>in vitro</i> antiviral activity of many repurposed drugs against SARS-CoV-2Tia A Tummino, Veronica V Rezelj, Benoit Fischer, et al.
Plos Pathogens|April 5, 2023
The E2 glycoprotein holds key residues for Mayaro virus adaptation to the urban Aedes aegypti mosquitoChelsea Cereghino, Ferdinand Roesch, Lucía Carrau, et al.
Nature Communications|April 17, 2021
Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hostsVeronica V Rezelj, Lucía Carrau, Fernando Merwaiss, et al.
Science (New York, N.Y.)|January 26, 2021
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1AKris M White, Romel Rosales, Soner Yildiz, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2Avi J Samelson, Quang Dinh Tran, Rémy Robinot, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Cell Death & Disease|October 28, 2016
ZIKA virus elicits P53 activation and genotoxic stress in human neural progenitors similar to mutations involved in severe forms of genetic microcephalyVincent El Ghouzzi, Federico T Bianchi, Ivan Molineris, et al.
Nature Communications|September 22, 2021
Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potentialBjoern Meyer, Jeanne Chiaravalli, Stacy Gellenoncourt, et al.
Cell Death & Disease|November 22, 2018
Correction to: ZIKA virus elicits P53 activation and genotoxic stress in human neural progenitors similar to mutations involved in severe forms of genetic microcephalyVincent El Ghouzzi, Federico T Bianchi, Ivan Molineris, et al.
Nature Communications|May 4, 2022
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screenAlice Mac Kain, Ghizlane Maarifi, Sophie-Marie Aicher, et al.
Journal of Virology|August 19, 2016
Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA VirusesBryan C Mounce, Teresa Cesaro, Gonzalo Moratorio, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
Phospholipidosis is a shared mechanism underlying the <i>in vitro</i> antiviral activity of many repurposed drugs against SARS-CoV-2Tia A Tummino, Veronica V Rezelj, Benoit Fischer, et al.
Plos Pathogens|April 5, 2023
The E2 glycoprotein holds key residues for Mayaro virus adaptation to the urban Aedes aegypti mosquitoChelsea Cereghino, Ferdinand Roesch, Lucía Carrau, et al.
Nature Communications|April 17, 2021
Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hostsVeronica V Rezelj, Lucía Carrau, Fernando Merwaiss, et al.
Science (New York, N.Y.)|January 26, 2021
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1AKris M White, Romel Rosales, Soner Yildiz, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2Avi J Samelson, Quang Dinh Tran, Rémy Robinot, et al.
Pageof 13